Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1

Human Molecular Genetics

Volumn 9, Issue 7, 2000, Pages 1059-1066

  Rutkowski, J Lynn ^a,e   Wu, Kunsheng ^e   Gutmann, David H ^b   Boyer, Philip J ^c   Legius, Eric ^d  

^a Departments of Neurology   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NEUROFIBROMIN;

ALLELE; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; FIBROBLAST; GENE INACTIVATION; HUMAN; HUMAN CELL; MALE; MOLECULAR GENETICS; NEUROFIBROMATOSIS; PERIPHERAL NERVE TUMOR; PRIORITY JOURNAL; SCHWANN CELL; TUMOR SUPPRESSOR GENE;

EID: 0034639937     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/9.7.1059     Document Type: Article

References (45)

1. Riccardi, V.M. (1992) Neurofibromatosis: Phenotype, Natural History and Pathogenesis. Johns Hopkins University Press, Baltimore, MD.
2. Huson, S.M. and Hughes, R.A. (1994) The Neurofibromatoses, a Pathological and Clinical Overview. Chapman & Hall, London, UK.
3. Shen, M.H., Harper, P.S. and Upadhyaya, M. (1996) Molecular genetics of neurofibromatosis type 1 (NF1). J. Med. Genet., 33, 2-17.
4. Knudson, A.G Jr, (1991) Overview: genes that predispose to cancer. Mutat. Res., 247, 185-190.
5. Menon, A.G. et al. (1990) Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc. Natl Acad. Sci. USA, 87, 5435-5439.
6. Skuse, G.R., Kosciolek, B.A. and Rowley, P.T. (1991) The neurofibroma in von Recklinghausen neurofibromatosis has a unicellular origin. Am. J. Hum. Genet., 49, 600-607.
7. Glover, T.W. et al. (1991) Molecular and cytogenetic analysis of tumors in von Recklinghausen neurofibromatosis. Genes Chromosomes Cancer, 3, 62-70.
8. Shimizu, E. et al. (1993) Loss of heterozygosity on chromosome arm 17p in small cell lung carcinomas, but not in neurofibromas, in a patient with von Recklinghausen neurofibromatosis. Cancer, 71, 725-728.
9. Lothe, R.A. et al. (1995) Alterations at chromosome 17 loci in peripheral nerve sheath tumors. J. Neuropathol. Exp. Neurol., 54, 65-73.
10. Daschner, K. et al. (1997) Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene. Biochem. Biophys. Res. Commun., 234, 346-350.
11. Colman, S.D., Williams, C.A. and Wallace, M.R. (1995) Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene. Nature Genet., 11, 90-92.
12. Serra, E. et al. (1997) Confirmation of a double-hit model for the NF1 gene in benign neurofibromas. Am. J. Hum. Genet., 61, 512-519.
13. Sawada, S. et al. (1996) Identification of NF1 mutations in both alleles of a dermal neurofibroma. Nature Genet., 14, 110-112.
14. Stefansson, K., Wollmann, R. and Jerkovic, M. (1982) S-100 protein in soft-tissue tumors derived from Schwann cells and melanocytes. Am. J. Pathol., 106, 261-268.
15. Weiss, S.W., Langloss, J.M. and Enzinger, P.M. (1983) Value of S-100 protein in the diagnosis of soft tissue tumors with particular reference to benign and malignant Schwann cell tumors. Lab. Invest., 49, 299-308.
16. Zelkowitz, M. (1981) Neurofibromatosis fibroblasts: abnormal growth and binding to epidermal growth factor. Adv. Neurol., 29, 173-189.
17. Kadono, T. et al. (1994) The growth regulation of neurofibroma cells in neurofibromatosis type-1: increased responses to PDGF-BB and TGF-β 1. Biochem. Biophys. Res. Commun., 198, 827-834.
18. Sheela, S., Riccardi, V.M. and Ratner, N. (1990) Angiogenic and invasive properties of neurofibroma Schwann cells. J. Cell Biol., 111, 645-653.
19. Atit, R.P., Crowe, M.J., Greenhalgh, D.G., Wenstrup, R.J. and Ratner, N. (1999) The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts. J. Invest. Dermatol., 112, 835-842.
20. Rosenbaum, T. et al. (1995) Neurofibromin-deficient fibroblasts fail to form perineurium in vitro. Development, 121, 3583-3592.
21. Kim, H.A., Rosenbaum, T., Marchionni, M.A., Ratner, N. and DeClue, J.E. (1995) Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes. Oncogene, 11, 325-335.
22. Kim, H.A., Ling, B. and Ratner, N. (1997) Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farnesyl protein transferase. Mol. Cell. Biol., 17, 862-872.
23. Kluwe, L., Friedrich, R. and Mautner, V.F. (1999) Loss of NF1 allele in Schwann cells but not in fibroblasts derived from an NF1-associated neurofibroma. Genes Chromosomes Cancer, 24, 283-285.
24. Stark, M., Assum, G. and Krone, W. (1995) Single-cell PCR performed with neurofibroma Schwann cells reveals the presence of both alleles of the neurofibromatosis type 1 (NF1) gene. Hum. Genet., 96, 619-623.
25. Gutmann, D.H. et al. (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. J. Am. Med. Assoc., 278, 51-57.
26. Wu, R. et al. (1999) Germline mutations in NF1 patients with malignancies. Genes Chromosomes Cancer, 26, 376-380.
27. Egelhoff, J.C., Bates, D.J., Ross, J.S., Rothner, A.D. and Cohen, B.H. (1992) Spinal MR findings in neurofibromatosis types 1 and 2. Am. J. Neuroradiol., 13, 1071-1077.
28. Poyhonen, M., Leisti, E.L., Kytola, S. and Leisti, J. (1997) Hereditary spinal neurofibromatosis: a rare form of NF1? J. Med. Genet., 34, 184-187.
29. Ars, E. et al. (1998) A clinical variant of neurofibromatosis type 1: familial spinal neurofibromatosis with a frameshift mutation in the NF1 gene. Am. J. Hum. Genet., 62, 834-841.
30. Pulst, S.M., Riccardi, V.M., Fain, P. and Korenberg, J.R. (1991) Familial spinal neurofibromatosis: clinical and DNA linkage analysis. Neurology, 41, 1923-1927.
31. Bharucha, V.A., Peden, K.W. and Tennekoon, G.I. (1994) SV40 large T antigen with c-Jun down-regulates myelin P0 gene expression: a mechanism for papovaviral T antigen-mediated demyelination. Neuron, 12, 627-637.
32. Rodenhiser, D.I., Coulter-Mackie, M.B. and Singh, S.M. (1993) Evidence of DNA methylation in the neurofibromatosis type 1 (NF1) gene region of 17q11.2. Hum. Mol. Genet., 2, 439-444.
33. Feigenbaum, L., Fujita, K., Collins, F.S. and Jay, G. (1996) Repression of the NF1 gene by Tax may explain the development of neurofibromas in human T-lymphotropic virus type 1 transgenic mice. J. Virol., 70, 3280-3285.
34. Liechti-Gallati, S., Schneider, V., Neeser, D. and Kraemer, R. (1999) Two buffer PAGE system-based SSCP/HD analysis: a general protocol for rapid and sensitive mutation screening in cystic fibrosis and any other human genetic disease. Eur. J. Hum. Genet., 7, 590-598.
35. Lopez Correa, C. et al. (1999) Molecular studies in 20 submicroscopic neurofibromatosis type 1 gene deletions. Hum. Mutat., 14, 387-393.
36. Kayes, L.M. et al. (1994) Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients. Am. J. Hum. Genet., 54, 424-436.
37. Wu, B.L., Austin, M.A., Schneider, G.H., Boles, R.G. and Korf, B.R. (1995) Deletion of the entire NF1 gene detected by the FISH: four deletion patients associated with severe manifestations. Am. J. Med. Genet., 59, 528-535.
38. Leppig, K.A. et al. (1997) Familial neurofibromatosis 1 microdeletions: cosegregation with distinct facial phenotype and early onset of cutaneous neurofibromata. Am. J. Med. Genet., 73, 197-204.
39. Wu, B.L., Schneider, G.H. and Korf, B.R. (1997) Deletion of the entire NF1 gene causing distinct manifestations in a family. Am. J. Med. Genet., 69, 98-101.
40. Gutmann, D.H., Tennekoon, G.I., Cole, J.L., Collins, F.S. and Rutkowski, J.L. (1993) Modulation of the neurofibromatosis type 1 gene product, neurofibromin, during Schwann cell differentiation. J. Neurosci. Res., 36, 216-223.
41. Rutkowski, J.L., Tennekoon, G.I. and McGillicuddy, J.E. (1992) Selective culture of mitotically active human Schwann cells from adult sural nerves. Ann. Neurol., 31, 580-586.
42. Rutkowski, J.L., Kirk, C.J., Lerner, M.A. and Tennekoon, G.I. (1995) Purification and expansion of human Schwann cells in vitro. Nature Med., 1, 80-83.
43. Gutmann, D.H. et al. (1996) Increased neurofibromatosis 1 gene expression in astrocytic tumors: positive regulation by p21-ras. Oncogene, 12, 2121-2127.
44. Korf, B.R. (1999) NNFF International NF1 Genetics Consortium Database. http://www.nf.org/nf1gene/nf1gene.home.html
45. Devriendt, K. et al. (1997) Skewed X-chromosome inactivation in female carriers of dyskeratosis congenita. Am. J. Hum. Genet., 60, 581-587.